Roche Signs Agreement to Acquire Memory Pharmaceuticals (MEMY) For $50 Million
Tweet Send to a Friend
Roche and Memory Pharmaceuticals (Nasdaq: MEMY) announced that the two companies have signed a definitive merger agreement for Roche to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


